Source link : https://www.newshealth.biz/health-news/astrazeneca-sues-generic-drugmakers-over-cancer-drug-patents/
AstraZeneca has launched new lawsuits against four generic drug manufacturers in an ongoing patent battle over its cancer drug Lynparza (olaparib), approved to treat ovarian, pancreatic, prostate, and breast cancers. In the new complaints issued January 9, AstraZeneca claims that generic drug companies Sandoz, Cipla, Natco Pharma, and Zydus Pharmaceuticals are planning to make and […]
Author : News Health
Publish date : 2025-02-03 06:07:39
Copyright for syndicated content belongs to the linked Source.